8-K filed Apr 29, 2026 at 08:05 ET
CTS Corp filed an 8-K furnishing an April 2026 investor presentation that provides updated FY2026 guidance: revenue $560-$580M and adjusted diluted EPS $2.35-$2.45. The presentation highlights strong growth in diversified end markets (industrial +14%, medical +25%, aero/defense +15%) offsetting a 3% decline in transportation. LTM revenue stands at $555M with adjusted EBITDA margin of 23%.